Deinsulinisation in type 2 diabetes: evidence-based strategies for safe treatment simplification “Approaches to reducing insulin in type 2 diabetes”
Giorda CB, Anelli V, Goglia U, et al.
Diabetes Res Clin Pract. Pub. online 11 Dec 2025.
Leggi
Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: a post hoc analysis of ONWARDS 1-5
Cheng AYY, Anil G, Canani L, et al.
Diabetes Obes Metab. Pub. online 12 Dec 2025.
Leggi
Midchildhood obesity after exposure to gestational diabetes mellitus: the SWIFT study in youth
Josefson JL, King AS, Sun B, et al.
Diabetes Care. Pub. online 11 Dec 2025.
Leggi
Injection-site and dermatologic reactions associated with glucagon-like peptide-1 receptor agonists: insights from meta-analysis of randomised controlled trials and real-world evidence
Taj S, Zuber M, Rashid M, et al.
Diabetes Obes Metab. Pub. online 15 Dec 2025.
Leggi
Obesity-associated cardiovascular risk and benefit from PCSK9 inhibition: a prespecified analysis from FOURIER
Kang YM, Giugliano RP, Keech AC, et al.
J Am Coll Cardiol. Pub. online 10 Dec 2025.
Leggi
Age at type 2 diabetes diagnosis and prevalence of obesity, hypertension, anxiety, and depression: a retrospective observational study
Barker MM, Slater T, Melanie J. Davies, et al.
Nutr Metab Cardiovasc Dis. Pub. online 13 Dec 2025.
Leggi
Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus
Candido R, Buzzetti R, Consoli A, et al.
Acta Diabetol. Pub. online 3 Dec 2025.
Leggi
EMA: Mounjaro – opinion on variation to marketing authorisation
The CHMP adopted an extension to an existing indication as follows: Mounjaro is indicated for the treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
11 dicembre 2025
Leggi
Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA1c for the diagnosis of type 2 diabetes
Wang Y, Ram J, Bianchi, C et al.
Diabetologia. Pub. online 12 Dec 2025.
Leggi
Automated insulin delivery is beneficial in adults with insulin-treated type 2 diabetes with and without GAD65 antibodies
Beck RW, Hirsch IB, Raghinaru D, et al.
Diabetes Care. Pub. online 5 Dec 2025.
Leggi